HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Does low-density lipoprotein fully explain atherosclerotic risk in familial hypercholesterolemia?

AbstractPURPOSE OF REVIEW:
Familial hypercholesterolemia (FH) is a monogenic disorder of elevated low-density lipoprotein cholesterol (LDL-C) from birth leading to increased risk for atherosclerotic cardiovascular disease. However, not all carriers of FH variants display an FH phenotype. Despite this fact, FH variants confer increased risk for atherosclerotic disease in population cohorts. An important question to consider is whether measurements of LDL-C can fully account for this risk.
RECENT FINDINGS:
The atherosclerotic risk associated with FH variants is independent of observed adult LDL-C levels. Modeling adult longitudinal LDL-C accounts for more of this risk compared to using a single measurement. Still, even when adjusting for observed longitudinal LDL-C in adult cohorts, FH variant carriers are at increased risk for coronary artery disease. Genetic analyses, observational studies, and clinical trials all suggest that cumulative LDL-C is a critical driver of cardiovascular risk that may not be fully appreciated by routine LDL-C measurements in adulthood. As such, FH variants confer risk independent of adult LDL-C because these variants increase cumulative LDL-C exposure starting from birth.
SUMMARY:
Both research and clinical practice focus on LDL-C measurements in adults, but measurements during adulthood do not reflect lifelong cumulative exposure to LDL-C. Genetic assessments may compliment clinical assessments by better identifying patients who have experienced greater longitudinal LDL-C exposure.
AuthorsShoa L Clarke
JournalCurrent opinion in lipidology (Curr Opin Lipidol) Vol. 34 Issue 2 Pg. 52-58 (04 01 2023) ISSN: 1473-6535 [Electronic] England
PMID36853849 (Publication Type: Review, Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
Chemical References
  • Cholesterol, LDL
Topics
  • Humans
  • Cholesterol, LDL
  • Hyperlipoproteinemia Type II
  • Atherosclerosis
  • Coronary Artery Disease
  • Heart Disease Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: